HALEOSLABS vs LYKALABS: Stock Comparison

Haleos Labs Limited vs Lyka Labs Limited

Live data: 22 July 2026, 3:06 PM IST • Source: NSE and company filings

Haleos Labs Limited is the larger company by market capitalisation. Haleos Labs Limited shows a higher ROE, a higher dividend yield and a higher net margin, while Lyka Labs Limited shows a lower P/E and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Haleos Labs Limited and Lyka Labs Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, HALEOSLABS is more favourable on 5 of 13 scored metrics and LYKALABS on 5These counts are context-free and are not an overall rating.

Key Differences

Market Cap
HALEOSLABS is the larger company
₹484 Cr vs ₹226 Cr
P/E Ratio
LYKALABS has a lower P/E
-20.64x vs 27.94x
P/B Ratio
LYKALABS has a lower P/B
2.24x vs 2.27x
EPS
HALEOSLABS has higher earnings per share
₹57.3 vs ₹-2.81
Dividend Yield
HALEOSLABS has a higher dividend yield
0.1% vs 0%
Qtr Sales Growth
LYKALABS has stronger quarterly sales growth
9.7% vs -15.7%
Qtr Profit Growth
LYKALABS has stronger quarterly profit growth
-35.4% vs -85.2%
ROE
HALEOSLABS has a higher ROE
8.44% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricHALEOSLABSLYKALABS
SectorHealthcare
IndustryPharmaceuticals

Price

MetricHALEOSLABSLYKALABS
Live Price₹1,522.4₹74.83
Day Change-3.09%1.19%
Volume28188,556
52-Week High₹1,774₹121.44
52-Week Low₹1,181₹44.1
Distance from 52W High-14.18%-38.38%

Valuation

MetricHALEOSLABSLYKALABS
Market Cap₹484 Cr₹226 Cr
P/E Ratio27.94x-20.64x
P/B Ratio2.27x2.24x
EPS₹57.3₹-2.81
Book Value₹706₹25.87
Dividend Yield0.1%0%

Growth

MetricHALEOSLABSLYKALABS
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth-15.7%9.7%
Qtr Profit Growth-85.2%-35.4%

Profitability & Leverage

MetricHALEOSLABSLYKALABS
ROE8.44%0%
ROCE9.91%9.91%
Net Margin5.33%-7.81%
Operating Margin13.4%-9.43%
Debt to Equity0.52x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricHALEOSLABSLYKALABS
Promoter Holding72.11%58.16%
FII Holding0%0.29% 0.12 pp
DII Holding0.31% 0.01 pp0.67%
Public Holding27.58% 0.02 pp40.88% 0.12 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Haleos Labs Limited and Lyka Labs Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.